Jobs

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform.

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform.

For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform.

About the Role


We are looking to appoint a Senior Partnerships Manager to support the Faculty of Science and Engineering in its relationships with businesses, focusing on the development of substantial research partnerships through strategic initiatives, collaborative schemes and contract research. The post-holder will be responsible for advancing the external engagement of relevant schools, working with academic leaders to deliver innovative business solutions for clients involving research and development, knowledge transfer, consultancy and use of facilities.

PolyProx Therapeutics is a spin-out from Cambridge University, Department of Pharmacology, based on exciting discoveries in the PROTACs/proteasome field.


The company is developing a new class of drugs for the treatment of cancer and other diseases, using novel engineered proteins that are able to selectively target tumour cells and trigger natural degradation machinery within the cell. This approach promises to address drug targets that have proved intractable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers.

THE COMPANY


Isogenica is a leading innovator in therapeutic antibody development, focused on enabling rapid advancement of next generation antibodies and antibody-based therapeutics through technical innovation.

Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.

The Archival Infrastructure and Technology (AIT) team is looking for an enthusiastic, highly motivated bioinformatician to join the Human Cell Atlas (HCA - https://www.humancellatlas.org) project. You will support labs from all over the world contributing single-cell data to the HCA. You will ensure this data is associated with a rich description and is interoperable so it can be combined with other data in order to build the Atlas.

We are looking for a highly motivated Bioinformatician/Senior Bioinformatician to contribute to the development of the analysis pipelines behind EMBL-EBI’s Expression Atlas and particularly the Single Cell Expression Atlas, an added-value database providing information about gene expression in single cells across different cell types, tissues and conditions, across all species. A significant part of your work will involve working on the pipelines that will process data from projects such as the Human Cell Atlas (HCA), Fly Cell Atlas.

Pages